Predictive performance of eGFR equations in South Africans of African and Indian ancestry compared with 99mTc-DTPA imaging |
| |
Authors: | Nomandla D. Madala Ntombifikile Nkwanyana Thozama Dubula Indiran P. Naiker |
| |
Affiliation: | 1. King Edward Hospital Renal Clinic, Department of Nephrology, Division of Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa 3. Department of Nephrology, Division of Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, P. O. Box 17039, Congella, 4013, South Africa 2. Programme of Bioethics and Medical Law, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
|
| |
Abstract: | Background South African guidelines for early detection and management of chronic kidney disease (CKD) recommend using the Cockcroft?CGault (CG) or Modification of Diet in Renal Disease (MDRD) equations for calculating estimated glomerular filtration rate (eGFR) with the correction factor, 1.212, included for MDRD-eGFR in black patients. We compared eGFR against technetium-99m-diethylenetriaminepentaacetic acid (99mTc-DTPA) imaging. Methods Using clinical records, we retrospectively recorded demographic, clinical, and laboratory data as well as 99mTc-DTPA-measured GFR (mGFR) results obtained from routine visits. Data from 148 patients of African (n?=?91) and Indian (n?=?57) ancestry were analyzed. Results Median (IQR) mGFR was 38.5 (44) ml/min/1.73?m2, with no statistical difference between African and Indian patients (P?=?0. 573). In African patients with stage 3 CKD, MDRD-eGFR (unadjusted for black ethnicity) overestimated mGFR by 5.3% [2.0 (16.0) ml/min/1.73?m2] compared to CG-eGFR and MDRD-eGFR (corrected for black ethnicity) that overestimated mGFR by 17.7% [6.0 (15.0) ml/min/1.73?m2] and 17.1% [6.0 (17.5) ml/min/1.73?m2], respectively. In stage 1?C2, CKD eGFR overestimated mGFR by 52.5, 38.0, and 19.3% for CG, MDRD (ethnicity-corrected), and MDRD (without correction), respectively. In Indian stage 3 CKD patients, MDRD-eGFR underestimated mGFR by 35.6% [?21.0 (6.5) ml/min/1.73?m2] and CG-eGFR by 4.4% [?2.0 (27.0) ml/min/1.73?m2], while in stage 1?C2 CKD, CG-eGFR and MDRD-eGFR overestimated mGFR by 13.8 and 6.3%, respectively. Conclusion MDRD-eGFR calculated without the African-American correction factor improved GFR prediction in African CKD patients and using the MDRD correction factor of 1.0 in Indian patients as in Caucasians may be inappropriate. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|